Cargando…
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
Background: Ibrutinib is widely known as an effective and well-tolerated therapeutical choice of the chronic lymphocytic leukaemia (CLL). However, acquired resistance may occur during the treatment, causing relapse. Early detection of ibrutinib resistance is an important issue, therefore we aimed to...
Autores principales: | Takács, Ferenc, Kotmayer, Lili, Czeti, Ágnes, Szalóki, Gábor, László, Tamás, Mikala, Gábor, Márk, Ágnes, Masszi, András, Farkas, Péter, Plander, Márk, Weisinger, Júlia, Demeter, Judit, Fekete, Sándor, Szerafin, László, Deák, Beáta Margit, Szaleczky, Erika, Sulák, Adrienn, Borbényi, Zita, Barna, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532522/ https://www.ncbi.nlm.nih.gov/pubmed/36213161 http://dx.doi.org/10.3389/pore.2022.1610659 |
Ejemplares similares
-
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
por: Kotmayer, Lili, et al.
Publicado: (2023) -
PB1909: LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION
por: László, Tamás, et al.
Publicado: (2023) -
Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers
por: Varga, Gergely, et al.
Publicado: (2021) -
Successful thrombolytic therapy is associated with increased granulocyte CD15 expression and reduced stroke‐induced immunosuppression
por: Béres‐Molnár, Katalin Anna, et al.
Publicado: (2022) -
Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
por: Varga, Gergely, et al.
Publicado: (2019)